Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) ('SEC') today announced that its Board of Directors has authorized the following related-party transaction with an affiliated company.
Trademark License Agreement
- Grant trademark license to Samsung Medicine

Transaction Item License fee for use of trademark
Transaction Date January 31, 2013
Transaction Period January 31, 2013-January 31, 2018
Transaction Value KRW 5,604 million (total transaction value: KRW 5,604 million)
Contract Type Negotiated Contract
Terms and Conditions * On a cumulative basis, the license fee was below KRW 5 billion at the end of 2016, but
exceeded KRW 5 billion after adding the fee for 2017. Accordingly, the payment shall be made upon the approval of the Board of Directors. * The transaction date is the date when the trade license agreement with Samsung Medicine
was made.
* The transaction value is the cumulative amount of the license fee during the transaction
period (five years).
* The license fee is set at 0.5% of Samsung Medicine's revenue (not including revenue from
licensor or revenue from consignment sales) each year during the transaction period

Other Information: · Number of Independent Directors Present at the BOD Meeting: 5 · Attendance of Audit Committee: Y
※ This disclosure is in accordance with the Korean Fair Trade Act, which mandates that a company must disclose
financial and real estate transactions in the event the value of such a transaction is greater or equal to KRW 5 billion
and the counterparty is a financial affiliate of the party required to make the disclosure.

Samsung Electronics Co. Ltd. published this content on 31 January 2018 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 31 January 2018 14:19:02 UTC.

Original documenthttp://www.samsung.com/global/ir/reports-disclosures/public-disclosure-view.71136/

Public permalinkhttp://www.publicnow.com/view/A9A8754C79E6AFD80D9882798819087DD40F4D4D